JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ignarro, L. J.
Right arrow Articles by Chaudhuri, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ignarro, L. J.
Right arrow Articles by Chaudhuri, G.

Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle

LJ Ignarro, GM Buga, RE Byrns, KS Wood and G Chaudhuri

Department of Pharmacology, UCLA School of Medicine.

The principal objective of this study was to compare and contrast the vascular smooth muscle-relaxing properties of endothelium-derived relaxing factor (EDRF) and nitric oxide (NO) in two different assay systems. In one system, precontracted rings of bovine intrapulmonary artery and vein and coronary artery were used to compare the relaxant effects of endothelium-dependent vasodilators, NO, S-nitroso-N- acetylpenicillamine, glyceryl trinitrate, prostacyclin and isoproterenol. In a second system, a bioassay superfusion cascade procedure was employed to compare the relaxant effects and biologic stability of EDRF and NO. Acetylcholine and bradykinin elicited concentration-dependent but transient relaxant responses in arterial and venous rings, respectively. NO and S-nitroso-N-acetylpenicillamine, which generates NO in solution, elicited similar transient relaxant responses in endothelium-denuded arterial and venous rings. Glyceryl trinitrate, however, produced sustained relaxations, as did isoproterenol and prostacyclin. Utilizing a bioassay superfusion cascade system in which intact perfused artery or vein was the source of EDRF and three endothelium-denuded arterial or venous strips mounted in series served as the detector of EDRF or NO, the relaxation profile and biologic stability of superfused EDRF were compared with those of superfused NO. Arterial or venous perfusion with acetylcholine or bradykinin, respectively, and superfusion of NO over the strips produced characteristic decremental relaxant responses in the three vascular strips and revealed the highly unstable nature of EDRF and NO (T1/2 = 3-5 sec for both). The relaxation profile of EDRF was indistinguishable from that of NO.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 246, Issue 1, pp. 218-226, 07/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. Katsumi, M. Nishikawa, F. Yamashita, and M. Hashida
Development of Polyethylene Glycol-Conjugated Poly-S-Nitrosated Serum Albumin, a Novel S-Nitrosothiol for Prolonged Delivery of Nitric Oxide in the Blood Circulation in Vivo
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1117 - 1124.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. A. Wink, K. M. Miranda, T. Katori, D. Mancardi, D. D. Thomas, L. Ridnour, M. G. Espey, M. Feelisch, C. A. Colton, J. M. Fukuto, et al.
Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2264 - H2276.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Coffey, R. Natarajan, P. H. Chumley, B. Coles, P.-R. Thimmalapura, M. Nowell, H. Kuhn, M. J. Lewis, B. A. Freeman, and V. B. O'Donnell
Catalytic consumption of nitric oxide by 12/15- lipoxygenase: Inhibition of monocyte soluble guanylate cyclase activation
PNAS, June 20, 2001; (2001) 141136098.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Ikebe, T. Akaike, Y. Miyamoto, K. Hayashida, J. Yoshitake, M. Ogawa, and H. Maeda
Protective Effect of S-Nitrosylated alpha 1-Protease Inhibitor on Hepatic Ischemia-Reperfusion Injury
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 904 - 911.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
V. B. O'Donnell, K. B. Taylor, S. Parthasarathy, H. Kuhn, D. Koesling, A. Friebe, A. Bloodsworth, V. M. Darley-Usmar, and B. A. Freeman
15-Lipoxygenase Catalytically Consumes Nitric Oxide and Impairs Activation of Guanylate Cyclase
J. Biol. Chem., July 16, 1999; 274(29): 20083 - 20091.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Fujino, I. Nagahiro, A. N. Triantafillou, C. H. R. Boasquevisque, M. Yano, J. D. Cooper, and G. A. Patterson
Inhaled Nitric Oxide at the Time of Harvest Improves Early Lung Allograft Function
Ann. Thorac. Surg., May 1, 1997; 63(5): 1383 - 1389.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
V. B. O'Donnell, B. Coles, M. J. Lewis, B. C. Crews, L. J. Marnett, and B. A. Freeman
Catalytic Consumption of Nitric Oxide by Prostaglandin H Synthase-1 Regulates Platelet Function
J. Biol. Chem., December 1, 2000; 275(49): 38239 - 38244.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Coffey, R. Natarajan, P. H. Chumley, B. Coles, P.-R. Thimmalapura, M. Nowell, H. Kuhn, M. J. Lewis, B. A. Freeman, and V. B. O'Donnell
Catalytic consumption of nitric oxide by 12/15- lipoxygenase: Inhibition of monocyte soluble guanylate cyclase activation
PNAS, July 3, 2001; 98(14): 8006 - 8011.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics.